Patents by Inventor Andreas Missel
Andreas Missel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10793896Abstract: The present invention is directed to methods for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction (RT-PCR).Type: GrantFiled: August 23, 2017Date of Patent: October 6, 2020Assignee: QIAGEN GmbHInventors: Nan Fang, Andreas Missel
-
Patent number: 10501783Abstract: The present invention relates to methods and uses for the detection or quantification of newly-synthesized double-stranded target nucleic acid molecules in a sample during quantitative real-time polymerase chain reaction (qPCR) amplification. According to the invention, an intercalating dye recognizing double-stranded DNA molecules with higher affinity than single-stranded DNA molecules and a fluorophore-labeled oligonucleotide-probe being sequence specific for a target nucleic acid molecule are simultaneously employed, thus enabling quantification a specific target and total amount of a mixed nucleic acid population, and enabling assessing the cause of suboptimal PCR performance.Type: GrantFiled: December 9, 2014Date of Patent: December 10, 2019Assignee: QIAGEN GMBHInventors: Nan Fang, Andreas Missel, Katja Heitz, Holger Wedler
-
Publication number: 20170356026Abstract: The present invention is directed to methods for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction (RT-PCR).Type: ApplicationFiled: August 23, 2017Publication date: December 14, 2017Inventors: Nan FANG, Andreas MISSEL
-
Patent number: 9758812Abstract: The present invention is in the fields of molecular biology. The present invention is directed to novel compositions, methods and kits useful for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction.Type: GrantFiled: August 13, 2012Date of Patent: September 12, 2017Assignee: Qiagen GmbHInventors: Nan Fang, Andreas Missel
-
Patent number: 9587267Abstract: The invention relates to a method for the quantification of one or more nucleic acids in a sample, for example: making a sample available which contains at least one nucleic acid to be quantified, adding an oligonucleotide probe, the oligonucleotide probe comprising a sequence which can specifically hybridize to the nucleic acid to be quantified or to a common sequence of the nucleic acids to be quantified, incubating the sample under conditions which allow the hybridization of the oligonucleotide probe to the nucleic acid(s) to be quantified, incubating the sample under conditions which allow the extension of hybridized probes, the nucleic acid(s) serving as a template in each case, removing the non-hybridized probes from the sample and quantifying the hybridized oligonucleotide probes to measure the quantity of the nucleic acid(s) to be quantified. The invention also relates to a kit for carrying out said method.Type: GrantFiled: March 9, 2010Date of Patent: March 7, 2017Assignee: QIAGEN GMBHInventors: Nan Fang, Andreas Missel, Dirk Löffert
-
Publication number: 20160298182Abstract: The present invention relates to methods and uses for the detection or quantification of newly-synthesized double-stranded target nucleic acid molecules in a sample during quantitative real-time polymerase chain reaction (qPCR) amplification. According to the invention, an intercalating dye recognizing double-stranded DNA molecules with higher affinity than single-stranded DNA molecules and a fluorophore-labeled oligonucleotide-probe being sequence specific for a target nucleic acid molecule are simultaneously employed, thus enabling quantification a specific target and total amount of a mixed nucleic acid population, and enabling assessing the cause of suboptimal PCR performance.Type: ApplicationFiled: December 9, 2014Publication date: October 13, 2016Inventors: Nan Fang, Andreas Missel, Katja Heitz, Holger Wedler
-
Publication number: 20140212884Abstract: The present invention is in the fields of molecular biology. The present invention is directed to novel compositions, methods and kits useful for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction.Type: ApplicationFiled: August 13, 2012Publication date: July 31, 2014Applicant: QIAGEN GMBHInventors: Nan Fang, Andreas Missel
-
Publication number: 20140154748Abstract: Novel thermostable chimeric nucleic acid polymerases and methods for their generation and use are disclosed. It is shown that these chimeric nucleic acid polymerases, such as DNA polymerases, can be constructed using enzymatically active domains, isolated from different proteins or chemically synthesized. It is demonstrated that chimeric nucleic acid polymerases of the present invention possess the chemical and physical properties of their component domains (e.g., exonuclease activity, thermostability) and that the chimeric polymerases are thermostable.Type: ApplicationFiled: December 17, 2013Publication date: June 5, 2014Applicant: QIAGEN GMBHInventors: Dirk Löffert, Andreas Missel, Jie Kang
-
Patent number: 8637288Abstract: Novel thermostable chimeric nucleic acid polymerases and methods for their generation and use are disclosed. It is shown that these chimeric nucleic acid polymerases, such as DNA polymerases, can be constructed using enzymatically active domains, isolated from different proteins or chemically synthesized. It is demonstrated that chimeric nucleic acid polymerases of the present invention possess the chemical and physical properties of their component domains (e.g., exonuclease activity, thermostability) and that the chimeric polymerases are thermostable.Type: GrantFiled: August 8, 2002Date of Patent: January 28, 2014Assignee: Qiagen, GmbHInventors: Dirk Löffert, Andreas Missel, Jie Kang
-
Publication number: 20120107813Abstract: The invention relates to a method for the quantification of one or more nucleic acids in a sample. The method comprises the following steps: making a sample available which contains at least one nucleic acid to be quantified, adding an oligonucleotide probe to the sample, the oligonucleotide probe comprising a sequence which can specifically hybridize to the nucleic acid to be quantified or to a common sequence of the nucleic acids to be quantified, incubating the sample under conditions which allow the hybridization of the oligonucleotide probe to the nucleic acid(s) to be quantified, incubating the sample under conditions which allow the extension of hybridized probes, the nucleic acid(s) serving as a template in each case, removing the non-hybridized probes from the sample and quantifying the hybridized oligonucleotide probes to measure the quantity of the nucleic acid(s) to be quantified. The invention also relates to a kit for carrying out said method.Type: ApplicationFiled: March 9, 2010Publication date: May 3, 2012Inventors: Nan Fang, Andreas Missel, Dirk Löffert
-
Patent number: 8129150Abstract: The invention relates to composition or a kit containing an enzyme that is reversibly inhibited by means of a chemical modification and an enzyme which is reversibly inhibited using non-covalent binding, the use of a mixture of enzymes reversibly inhibited in such a manner for processing or multiplying polynucleotides, and a method for specifically amplifying DNA by simultaneously using both types of reversibly inhibited enzymes.Type: GrantFiled: March 30, 2007Date of Patent: March 6, 2012Assignee: QIAGEN GmbHInventors: Holger Engel, Dirk Löffert, Andreas Missel, Ralf Peist
-
Publication number: 20090117622Abstract: The invention relates to composition or a kit containing an enzyme that is reversibly inhibited by means of a chemical modification and an enzyme which is reversibly inhibited using non-covalent binding, the use of a mixture of enzymes reversibly inhibited in such a manner for processing or multiplying polynucleotides, and a method for specifically amplifying DNA by simultaneously using both types of reversibly inhibited enzymes.Type: ApplicationFiled: March 30, 2007Publication date: May 7, 2009Applicant: QIAGEN GmbHInventors: Holger Engel, Dirk Loffert, Andreas Missel, Ralf Peist
-
Publication number: 20030138805Abstract: Novel thermostable chimeric nucleic acid polymerases and methods for their generation and use are disclosed. It is shown that these chimeric nucleic acid polymerases, such as DNA polymerases, can be constructed using enzymatically active domains, isolated from different proteins or chemically synthesized. It is demonstrated that chimeric nucleic acid polymerases of the present invention possess the chemical and physical properties of their component domains (e.g., exonuclease activity, thermostability) and that the chimeric polymerases are thermostable.Type: ApplicationFiled: August 8, 2002Publication date: July 24, 2003Inventors: Dirk Loffert, Andreas Missel, Jie Kang
-
Patent number: 6300069Abstract: Novel compositions and methods useful for the generation of nucleic acids from a ribonucleic acid template and further nucleic acid replication are disclosed. It is shown that the generation and amplification of nucleic acids by methods that utilize two or more different polymerases, such as reverse transcriptase-polymerase chain reaction (RT-PCR), are dramatically more sensitive and efficient in the presence of a homopolymeric nucleic acid. Homopolymeric nucleic acids have been found to reduce or negate the inhibitory effect reverse transcriptases have on DNA polymerase activity. It is demonstrated that this inhibition-relieving effect of homopolymeric nucleic acids is general in nature; independent of the chemical species of homopolymer used, or the chemical composition of the polymerization reaction mixture.Type: GrantFiled: May 3, 1999Date of Patent: October 9, 2001Assignee: Qiagen GmbHInventors: Andreas Missel, Dirk Löffert, Jie Kang, Christian Korfhage